FIGURE 5.  Scintigraphy performed 4 d after administration of 7.4 GBq ¹⁷⁷Lu-octreotate in patient with SCLC. (A) Scan (posterior chest) after first dose. Arrow indicates a cervical lesion. (B) Scan (posterior chest) after second and last dose 2 mo later. Several new lesions are visible (arrowheads). Uptake in lesions already present on first scan has increased (arrow).